Skip to main content

Lenovo launches 20 new laptops with 5th Generation Intel processors, from Rs.39790

Enjoy big offers till 15th August. Goods and offers bought on this store are directly brand authorized.
View range and buy now >
Intel® Core™ i7 processor
Lenovo
Lenovo
GET THINGS DONE WITH A SMILE.
LITERALLY.
The new range of Lenovo™ laptops with Intel® 5th generation processors responds to your gestures and facial expressions.
Powered by the latest Intel 5th generation processors, our laptops surpass all benchmarks in computing. These machines bring you a new wave of innovations including 3D printing, gesture control, voice commands and more. Now everything from opening an app to creating complicated graphics will be faster, smarter, smoother.  
2.5x PRODUCTIVITY
2.5x PRODUCTIVITY
Save time as you move effortlessly between applications
3.5x FASTER 3D PRINTING
3.5x FASTER
3D PRINTING
Get 3D images ready for
printing at never-before speeds
12x TIMES BETTER GAMING EXPERIENCE
12x TIMES BETTER
GAMING EXPERIENCE
Play 3D games a lot smoother and faster
WIDEST RANGE OF 5TH GEN LAPTOPS AVAILABLE ONLY ON THEDOSTORE.COM
U SERIES
U SERIES
The lightweight heavyweight
View Range
Y SERIES
Y SERIES
The gaming powerhouse
View Range
Starting at just Rs.39,790
Z SERIES
Z SERIES
Serious about entertainment
View Range
THINKPAD X SERIES
THINKPAD® X SERIES
Built for business
View Range
BUY A 5TH GEN LENOVO LAPTOP BEFORE 15TH AUGUST AND GET OFFERS WORTH 14,999/-
Lenovo Power Bank
Lenovo Power Bank PA13000 - 13000 mAH 
 
Lenovo 1TB HDD
Lenovo 1TB HDD/Lenovo 500 Bluetooth® Speaker 
 
Total 3 Years Warranty
Total 3 Years Warranty Worth 4,599
 
Microsoft Office 365
Microsoft Office 365 Personal worth 3,299 with free 1TB Storage 
Visit thedostore.com, Lenovo's official online store, for factory sealed genuine products and after sale services that guarantee you peace of mind, like nowhere else.
Lenovo reserves the right to alter product offerings and specifications at any time without notice. Models pictured are for illustration purposes only. Information advertised has no contractual effect. Lenovo, the Lenovo logo and ThinkPad are trademarks or registered trademarks of Lenovo. Intel, the Intel logo, Intel Inside, Intel Core and Core Inside are trademarks of Intel Corporation in the U.S. and/or other countries. Microsoft and Windows are registered trademarks of Microsoft Corporation in the U.S. and/or other countries. © Lenovo 2015. All rights reserved.

Comments

Post a Comment

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with nonalcoholic steatoh
Post a Comment
Read More

J&J, Merck and Bristol Myers Squibb are in the hot seat

VIEW IN BROWSER | SUBSCRIBE TUE, JAN 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com .    Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks ahead.    CEOs from those companies are slated to testify at a Senate hearing on high prescription drug prices in the U.S. on Feb. 8 at 10 a.m. ET, Sen. Bernie Sanders announced Friday.   It took subpoena threats from the senator, but J&J CEO Joaquin Duato and Merck CEO Robert Davis have agreed to testify after both executives declined earlier requests to appear at the Senate HELP committee's hearing. They join Bristol Myers Squibb CEO Chris Boerner, who agr
Post a Comment
Read More

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – caused a higher rate of side
Post a Comment
Read More